Table 2 Baseline Characteristics of those whose treatment was changed due to pre-transfer surveillance labs versus those where labs were measured but treatment was not changed
|  | Patients with change in hormones (N = 175) | Patients without change in hormones (N = 349) | p-value |
|---|---|---|---|
Mean Age (years) | 34.2 (+ 4.8) | 34.8 (+ 4.1) | 0.2 |
Mean BMI (kg/m2) | 26.8 (+ 5.8) | 23.6 (+ 4.8) | < 0.001 |
Endometrial stripe (mm) | 10 (+ 2.4) | 9.6 (+ 2.1) | 0.06 |
Infertility Diagnosis (%) | Unexplained – (23%) | Unexplained – (27%) | 0.3 |
DOR – (3%) | DOR – (7%) | ||
Endometriosis – (5%) | Endometriosis – (3%) | ||
Ovulation disorders – (11%) | Ovulation disorders – (10%) | ||
Male factor – (25%) | Male factor – (19%) | ||
Othera – (33%) | Othera – (34%) | ||
Number of embryos transferred per cycle, n (%) | 1–118 (67.4%) | 1–233 (67%) | 0.8 |
2–56 (32%) | 2–112 (32%) | ||
3–1 (0.6%) | 3–4 (1%) | ||
PGT testing of embryo, n (%) | 46/175 (26%) | 121/349 (35%) | 0.05 |